[go: up one dir, main page]

SG165370A1 - Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites - Google Patents

Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites

Info

Publication number
SG165370A1
SG165370A1 SG201006597-7A SG2010065977A SG165370A1 SG 165370 A1 SG165370 A1 SG 165370A1 SG 2010065977 A SG2010065977 A SG 2010065977A SG 165370 A1 SG165370 A1 SG 165370A1
Authority
SG
Singapore
Prior art keywords
crc
diagnosis
present
relates
vitamin
Prior art date
Application number
SG201006597-7A
Other languages
English (en)
Inventor
Shawn Ritchie
Dayan Goodenowe
Original Assignee
Phenomenome Discoveries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenomenome Discoveries Inc filed Critical Phenomenome Discoveries Inc
Publication of SG165370A1 publication Critical patent/SG165370A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
SG201006597-7A 2005-09-12 2006-09-12 Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites SG165370A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71631005P 2005-09-12 2005-09-12
US80476406P 2006-06-14 2006-06-14

Publications (1)

Publication Number Publication Date
SG165370A1 true SG165370A1 (en) 2010-10-28

Family

ID=37865285

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2012041315A SG182169A1 (en) 2005-09-12 2006-09-12 Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
SG201006597-7A SG165370A1 (en) 2005-09-12 2006-09-12 Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2012041315A SG182169A1 (en) 2005-09-12 2006-09-12 Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites

Country Status (8)

Country Link
US (2) US10697969B2 (fr)
EP (2) EP3165925B1 (fr)
JP (1) JP5038311B2 (fr)
KR (1) KR20080049821A (fr)
AU (1) AU2006291988B2 (fr)
CA (3) CA2772688A1 (fr)
SG (2) SG182169A1 (fr)
WO (1) WO2007030928A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3231789A1 (fr) 2006-05-26 2017-10-18 Phenomenome Discoveries Inc. Biomarqueurs pour le diagnostic de la sclérose en plaques et procédés associés
EP2096439A4 (fr) 2006-12-21 2011-01-05 Ajinomoto Kk Procede, appareil, procede, systeme et logiciel d'evaluation du cancer colorectal, et support d'enregistrement
CA2676109C (fr) 2007-02-01 2018-03-20 Phenomenome Discoveries Inc. Procedes de diagnostic d'etats de sante associes au cancer des ovaires, et de risque de tels etats
AU2007346587C1 (en) 2007-02-08 2015-01-22 Med-Life Discoveries Lp Methods for the treatment of Senile Dementia of the Alzheimer's Type
WO2009086297A2 (fr) * 2007-12-21 2009-07-09 The Board Of Regents Of The University Of Oklahoma Identification de marqueurs biologiques dans des échantillons biologiques et leurs procédés d'utilisation
EP2279417B1 (fr) * 2008-05-28 2016-07-20 Georgia Tech Research Corporation Biomarqueurs métaboliques pour le cancer des ovaires et procédés pour leur utilisation
US10024857B2 (en) 2009-10-01 2018-07-17 Med-Life Discoveries Lp Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis
CA2799757C (fr) 2010-05-21 2018-12-04 The Governors Of The University Of Alberta Methodes de diagnostic du cancer colorectal et des polypes colorectaux faisant appel au dosage de metabolites urinaires
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
CN103797365A (zh) * 2011-09-14 2014-05-14 巴斯夫欧洲公司 用于评估性腺毒性的手段和方法
GB2545361B (en) 2015-04-10 2018-01-24 Applied Proteomics Inc Methods of assessing colorectal cancer status
US10006925B2 (en) 2016-05-30 2018-06-26 Universal Diagnostics, S. L. Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps
US11073522B2 (en) 2016-10-03 2021-07-27 Lincoln Memorial University Structural validation of very long chain dicarboxylic acids
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
EP3638683A4 (fr) * 2017-06-15 2021-03-03 Med-Life Discoveries LP Dimères d'acides gras dicarboxyliques, et leurs dérivés en tant qu'étalons de références pour quantifier des niveaux dans des échantillons biologiques
US11840720B2 (en) 2019-12-23 2023-12-12 Metabolomic Technologies Inc. Urinary metabolomic biomarkers for detecting colorectal cancer and polyps
CN114839298B (zh) * 2019-12-28 2024-06-07 中精普康(北京)医药科技有限公司 一种用于检测结直肠癌或腺瘤的生物标志物及其方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978852A (en) 1988-09-08 1990-12-18 Cornell Research Foundation, Inc. Hadamard transform measurement of MSN Fourier-transform mass spectra
US4956788A (en) 1988-11-28 1990-09-11 University Of The Pacific PC-based FT/ICR system
US5233190A (en) 1990-03-16 1993-08-03 Leybold Inficon Inc. Fourier transform molecular spectrometer
US6017693A (en) 1994-03-14 2000-01-25 University Of Washington Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry
US5668373A (en) 1996-04-26 1997-09-16 Trustees Of Tufts College Methods and apparatus for analysis of complex mixtures
GB9617852D0 (en) 1996-08-27 1996-10-09 Univ Manchester Metropolitan Micro-organism identification
GB9624927D0 (en) 1996-11-29 1997-01-15 Oxford Glycosciences Uk Ltd Gels and their use
US6428956B1 (en) 1998-03-02 2002-08-06 Isis Pharmaceuticals, Inc. Mass spectrometric methods for biomolecular screening
CA2339817A1 (fr) 1998-08-12 2000-02-24 Zycos Inc. Etablissement de profil et catalogage de marqueurs de proteines exprimees
US20020009394A1 (en) 1999-04-02 2002-01-24 Hubert Koster Automated process line
CA2303758C (fr) 1999-04-06 2004-01-06 Micromass Limited Methodes ameliorees d'identification des peptides et des proteines par spectrometrie de masse
DE60026452T2 (de) 1999-04-06 2006-08-10 Micromass Uk Ltd. Verfahren zur Identifizierung von Peptidensequenzen und Proteinensequenzen mittels Massenspektromterie
IL146093A0 (en) 1999-04-20 2002-07-25 Target Discovery Inc Method of separating a polypeptide or protein from a solution containing a plurality thereof
US6677114B1 (en) 1999-04-20 2004-01-13 Target Discovery, Inc. Polypeptide fingerprinting methods and bioinformatics database system
US6446010B1 (en) 1999-06-15 2002-09-03 The Rockefeller University Method for assessing significance of protein identification
CA2298181C (fr) 2000-02-02 2006-09-19 Dayan Burke Goodnough Analyse d'echantillons complexes non-cibles
DE60127813T2 (de) 2000-02-07 2007-12-27 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur identifizierung und/oder charakterisierung eines (poly)peptides
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
WO2001078652A2 (fr) 2000-04-14 2001-10-25 Metabolon, Inc. Procedes permettant de decouvrir des medicaments, de traiter des maladies et de poser des diagnostics a l'aide de la metabolomique
AU2001264867A1 (en) 2000-05-31 2001-12-11 The Johns Hopkins University Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen
SE517259C2 (sv) 2000-06-14 2002-05-14 Jan Eriksson System för molekylidentifiering
US6680203B2 (en) * 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
DE10100238A1 (de) 2001-01-05 2002-08-22 Hannover Med Hochschule Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests
EP1417629B1 (fr) 2001-07-06 2008-02-20 Lipomics Technologies, Inc. Methodes permettant de generer, visualiser, interpreter et utiliser une base de donnees quantitatives de metabolites
WO2003014724A1 (fr) * 2001-08-03 2003-02-20 Biotron Limited Nouveau marqueur du cancer et ses utilisations dans le diagnostic du cancer
EP1425695A2 (fr) 2001-08-13 2004-06-09 Beyong Genomics, Inc. Procede et systeme pour l'etablissement de profils de systemes biologiques
US20030108876A1 (en) 2001-12-11 2003-06-12 Speir Johnny Paul Method for the application of FTMS to drug testing
US7109038B2 (en) 2002-06-13 2006-09-19 The Johns Hopkins University Occult blood detection in biological samples by laser desorption and matrix-assisted laser desorption/ionization mass spectrometry for biomedical applications
CA2526878A1 (fr) * 2003-04-08 2004-10-21 Colotech A/S Procede de detection d'un cancer colorectal dans des echantillons humains
WO2004102190A1 (fr) * 2003-05-15 2004-11-25 Europroteome Ag Diagnostic differentiel du cancer colorectal et d'autres maladies du colon
CA2579034A1 (fr) 2004-07-30 2006-05-04 Mount Sinai School Of Medicine Of New York University Formes alternatives d'epissure de klf6 et polymorphisme d'adn de klf6 de cellules germinales associes a un risque accru de cancer

Also Published As

Publication number Publication date
US20160377622A1 (en) 2016-12-29
AU2006291988B2 (en) 2013-02-28
CA2619732A1 (fr) 2007-03-22
CA2619732C (fr) 2012-06-12
US20210041444A1 (en) 2021-02-11
CA2772688A1 (fr) 2007-03-22
WO2007030928A3 (fr) 2007-05-03
JP5038311B2 (ja) 2012-10-03
EP1931995A2 (fr) 2008-06-18
SG182169A1 (en) 2012-07-30
KR20080049821A (ko) 2008-06-04
EP3165925A1 (fr) 2017-05-10
WO2007030928A2 (fr) 2007-03-22
JP2009508091A (ja) 2009-02-26
AU2006291988A1 (en) 2007-03-22
EP1931995A4 (fr) 2010-08-04
EP3165925B1 (fr) 2021-09-08
US10697969B2 (en) 2020-06-30
WO2007030928A8 (fr) 2007-06-14
CA2881326A1 (fr) 2007-03-22

Similar Documents

Publication Publication Date Title
SG165370A1 (en) Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
CY1120296T1 (el) ΔΙΑΛΥΤΟΣ ΥΠΟΔΟΧΕΑΣ ΕΝΕΡΓΟΠΟΙΗΤΗ ΤΟΥ ΠΛΑΣΜΙΝΟΓΟΝΟΥ ΤΥΠΟΥ ΟΥΡΟΚΙΝΑΣΗΣ (suPAR) ΩΣ ΔΙΑΓΝΩΣΤΙΚΟΣ ΔΕΙΚΤΗΣ ΓΙΑ ΧΑΜΗΛΟΥ ΒΑΘΜΟΥ ΦΛΕΓΜΟΝΗ
WO2009037572A3 (fr) Combinaisons de bio-marqueurs du cancer colorectal
WO2010033371A3 (fr) Marqueurs moléculaires pour les carcinomes pulmonaires et colorectaux
WO2006089212A3 (fr) Cyr61 comme biomarqueur pour le diagnostic et le pronostic de cancers d'origine epitheliale
WO2012018535A3 (fr) Panneau de bien-être
ATE490465T1 (de) Diagnose- und prognoseverfahren von blasenkrebs.
WO2010027903A8 (fr) Diagnostic du cancer du poumon
WO2008008284A3 (fr) Biomarqueurs du cancer et méthodes d'utilisation
MX2010000405A (es) Seleccion de farmacos para terapia de cancer de pulmon usando arreglos a base de anticuerpos.
MY184498A (en) Methods for the diagnosis of ovarian cancer health states and risk of ovarian cancer health states
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
WO2007140352A3 (fr) Membrane plasmatique et biomarqueurs de cancer sécrétés
HK1259001A1 (zh) 癌症的预後和诊断方法
WO2013057581A8 (fr) Biomarqueurs composites pour criblage, diagnostic et pronostic non invasifs de cancer colorectal
CY1114386T1 (el) Διαγνωση καρκινου του προστατη
CA2701341A1 (fr) Procede de detection du cancer colorectal a partir d'un echantillon de selles au moyen d'une combinaison de marqueurs associant la calprotectine et le complexe hemoglobine/haptoglobine
MX339340B (es) Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico.
EP4621804A3 (fr) Procédés, dispositifs et système pour fournir un diagnostic et une thérapie d'état diabétique
MX2012007009A (es) Método para diagnosticar un tumor maligno.
WO2004021008A3 (fr) Methodes de detection du cancer du sein et des ovaires
WO2004021009A3 (fr) Techniques de detection de cancer du systeme endocrinien
WO2007030949A3 (fr) Procedes de diagnostic de cancer des ovaires et necessaires a cet effet
BR112019006404A2 (pt) métodos para diagnóstico e tratamento de câncer de próstata metastático resistente à castração sensível ou resistente a acetato de abiraterona-glicocorticoide
WO2015006657A3 (fr) Méthode de diagnostic et de pronostic du cancer